Implantica will begin commercializing RefluxStop in Spain and Italy


"Implantica AG (publ) today announces that the company will start commercializing RefluxStop™ on a reimbursed basis in Italy and Spain based on local/regional hospital agreements."


"Implantica will now focus on providing RefluxStop™ to the leading anti-reflux surgeons and centers in Italy and Spain. Surgical training will commence initially via webinar with representatives from Germany and Switzerland until Covid-19 subsides..."



021521 Implantica makes headway in Italy
.
Download • 76KB



Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887

Website: www.medicalandpharmainsider.com

Email mail@medicalandpharmainsider.com

MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2021 Medical and Pharma Insider and FC Global Strategies LLC